dihexa cancer risk hgf c met c-met Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF-c-Met Axis in Head – Targeting cancer-associated fibroblast-activated HGF/c-MET pathway
Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect dihexa cancer risk hgf c met Targeting the HGF c MET pathway in advanced pancreatic cancer Molecular mechanism(s) of regulation(s) of c MET HGF signaling in head and neck cancer Molecular Cancer Springer Nature Link Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



